Industry Symposium: Nanostring

Dr. Aleix Prat
Dr. Andreas Makris
16 Jan 2018
12:50-13:50
Charter 2 & 3
Back

Industry Symposium: Nanostring

Prosigna in context: Clinical evidence and comparative performance with other multi-parameter tests

12.50
Perspective and experience of clinical implications of breast cancer molecular subtype
Dr Aleix Prat
13.10
Prosigna data and beyond: Comparison of genomic tests
Dr Ivana Sestak
13.30
Prosigna in the UK: OPTIMA trial, and other perspectives
Dr Andreas Makris